Use of extracellular vesicles as a therapeutic option for graft-versus-host disease: systematic review of in vivo studies.
Nathalia Akemi Camargo Koga, Sarah Miranda Bezerra Alves, Graziela Garrido Mori
✦ AI-curated · Sources linked
In 30 seconds
This systematic review evaluated the therapeutic potential of extracellular vesicles (EVs) in animal models of graft-versus-host disease (GVHD). Out of 3468 articles, 14 studies were included, showing that EVs effectively controlled GVHD development, reduced tissue inflammation, and increased survival rates. The findings suggest a promising role for EVs in GVHD management, though further research is necessary.
Key findings
- EVs controlled GVHD development with reduced tissue inflammatory processes.
- Survival rates increased following EV administration in animal models.
- EV treatment led to an increase in anti-inflammatory cytokines and regulatory T cells.
- A decrease in inflammatory cytokines and activation of Th1 and Th17 lymphocytes was observed.
Why it matters
Understanding the role of extracellular vesicles in managing GVHD could lead to innovative therapeutic strategies. This research highlights a potential avenue for improving patient outcomes in conditions characterized by severe immune responses.